3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Recurrence
1
Medulloblastoma
1
Glioma
1
Glioblastoma
1
Astrocytoma
1
Interventions
Temozolomide
15
Filgrastim
13
Cyclophosphamide
9
Carboplatin
9
Granulocyte Colony-Stimulating Factor
7
Etoposide
7
Thiotepa
5
Peripheral Blood Stem Cell Transplantation
5
Melphalan
5
Vorinostat
4
Busulfan
4
sonidegib
3
ribociclib
3
Vincristine
3
Topotecan
3
O(6)-benzylguanine
3
Magnetic Resonance Spectroscopy
3
Irinotecan
3
Automobiles
3
veliparib
2
sargramostim
2
pembrolizumab
2
fludarabine
2
etoposide phosphate
2
Valproic Acid
2
Thalidomide
2
Surgical Procedures, Operative
2
Stem Cell Transplantation
2
Specimen Handling
2
Radiotherapy, Intensity-Modulated
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Medulloblastoma
×
Diphtheria Toxoid
×
Clear all
NCT03615404
2021-01-28
ATTAC-P
Duke University
Phase 1
Completed
11 enrolled
7 charts